BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 32188793)

  • 21. Atrial cardiomyopathy markers predict ischemic cerebrovascular events independent of atrial fibrillation in patients with acute myocardial infarction.
    Li Z; Wang X; Liu Q; Li C; Gao J; Yang Y; Wang B; Hidru TH; Liu F; Yang X; Xia Y
    Front Cardiovasc Med; 2022; 9():1025842. PubMed ID: 36483626
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The association between acute mental stress and abnormal left atrial electrophysiology.
    O'Neal WT; Hammadah M; Sandesara PB; Almuwaqqat Z; Samman-Tahhan A; Gafeer MM; Abdelhadi N; Wilmot K; Al Mheid I; Bremner DJ; Kutner M; Soliman EZ; Shah AJ; Quyyumi AA; Vaccarino V
    J Cardiovasc Electrophysiol; 2017 Oct; 28(10):1151-1157. PubMed ID: 28727203
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical significance of B-type natriuretic Peptide in the assessment of untreated hypertension.
    Seki S; Tsurusaki T; Kasai T; Taniguchi I; Mochizuki S; Yoshimura M
    Circ J; 2008 May; 72(5):770-7. PubMed ID: 18441458
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Molar Ratio of N-terminal pro-B-type Natriuretic Peptide/B-type Natriuretic Peptide for Heart Failure-related Events in Stable Outpatients with Cardiovascular Risk Factors.
    Suzuki S; Sugiyama S
    Intern Med; 2018 Sep; 57(18):2621-2630. PubMed ID: 29709934
    [TBL] [Abstract][Full Text] [Related]  

  • 25. B-type natriuretic peptide for incident atrial fibrillation-The Heinz Nixdorf Recall Study.
    Kara K; Geisel MH; Möhlenkamp S; Lehmann N; Kälsch H; Bauer M; Neumann T; Dragano N; Moebus S; Jöckel KH; Erbel R; Mahabadi AA
    J Cardiol; 2015 Jun; 65(6):453-8. PubMed ID: 25241013
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of BNP and NT-proBNP in Patients With Heart Failure and Reduced Ejection Fraction.
    Rørth R; Jhund PS; Yilmaz MB; Kristensen SL; Welsh P; Desai AS; Køber L; Prescott MF; Rouleau JL; Solomon SD; Swedberg K; Zile MR; Packer M; McMurray JJV
    Circ Heart Fail; 2020 Feb; 13(2):e006541. PubMed ID: 32065760
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictive value of plasma B-type natriuretic peptide for ischemic stroke: a community-based longitudinal study.
    Takahashi T; Nakamura M; Onoda T; Ohsawa M; Tanno K; Itai K; Sakata K; Sakuma M; Tanaka F; Makita S; Yoshida Y; Ogawa A; Kawamura K; Okayama A
    Atherosclerosis; 2009 Nov; 207(1):298-303. PubMed ID: 19497572
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Significance of electrocardiographic isolated abnormal terminal P-wave force (left atrial abnormality). An echocardiographic and clinical correlation.
    Jin L; Weisse AB; Hernandez F; Jordan T
    Arch Intern Med; 1988 Jul; 148(7):1545-9. PubMed ID: 2968074
    [TBL] [Abstract][Full Text] [Related]  

  • 29. P-wave terminal force in lead V1 is a predictive indicator for the diagnosis of tuberculous constrictive pericarditis.
    Ren Y; Qiu J; Li Z; Li C
    Heart Lung; 2019; 48(2):155-158. PubMed ID: 30391075
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The interplay between haemodynamic load, brain natriuretic peptide and left atrial size in the early stages of essential hypertension.
    Tsioufis C; Stougiannos P; Taxiarchou E; Skiadas I; Chatzis D; Thomopoulos C; Lalos S; Stefanadis C; Kallikazaros I
    J Hypertens; 2006 May; 24(5):965-72. PubMed ID: 16612260
    [TBL] [Abstract][Full Text] [Related]  

  • 31. N-terminal pro-brain natriuretic peptide and risk of cardiovascular events in a Japanese community: the Hisayama study.
    Doi Y; Ninomiya T; Hata J; Hirakawa Y; Mukai N; Ikeda F; Fukuhara M; Iwase M; Kiyohara Y
    Arterioscler Thromb Vasc Biol; 2011 Dec; 31(12):2997-3003. PubMed ID: 21921261
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is a pre-operative brain natriuretic peptide or N-terminal pro-B-type natriuretic peptide measurement an independent predictor of adverse cardiovascular outcomes within 30 days of noncardiac surgery? A systematic review and meta-analysis of observational studies.
    Karthikeyan G; Moncur RA; Levine O; Heels-Ansdell D; Chan MT; Alonso-Coello P; Yusuf S; Sessler D; Villar JC; Berwanger O; McQueen M; Mathew A; Hill S; Gibson S; Berry C; Yeh HM; Devereaux PJ
    J Am Coll Cardiol; 2009 Oct; 54(17):1599-606. PubMed ID: 19833258
    [TBL] [Abstract][Full Text] [Related]  

  • 33. B-Type Natriuretic Peptide and Ventricular Dysfunction in the Prediction of Cardiovascular Events and Death in Hypertension.
    Gallagher J; Watson C; Zhou S; Ryan F; Ledwidge M; McDonald K
    Am J Hypertens; 2018 Jan; 31(2):228-234. PubMed ID: 29036547
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Brain natriuretic peptide is a marker associated with thrombus in stroke patients with atrial fibrillation.
    Okada Y; Shibazaki K; Kimura K; Matsumoto N; Iguchi Y; Aoki J; Kobayashi K; Sakai K
    J Neurol Sci; 2011 Feb; 301(1-2):86-9. PubMed ID: 21094497
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Urinary N-terminal pro-B-type natriuretic peptide as a biomarker for cardiovascular events in a general Japanese population: the Hisayama Study.
    Yamasaki K; Hata J; Ide T; Nagata T; Sakata S; Yoshida D; Honda T; Hirakawa Y; Nakano T; Kitazono T; Tsutsui H; Ninomiya T
    Environ Health Prev Med; 2021 Apr; 26(1):47. PubMed ID: 33845756
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Electrocardiogram screening for left high R-wave predicts cardiovascular death in a Japanese community-based population: NIPPON DATA90.
    Nakamura K; Okamura T; Hayakawa T; Kadowaki T; Kita Y; Okayama A; Ueshima H;
    Hypertens Res; 2006 May; 29(5):353-60. PubMed ID: 16832156
    [TBL] [Abstract][Full Text] [Related]  

  • 37. B-type natriuretic peptide predicts adverse cardiovascular events in pediatric outpatients with chronic left ventricular systolic dysfunction.
    Price JF; Thomas AK; Grenier M; Eidem BW; O'Brian Smith E; Denfield SW; Towbin JA; Dreyer WJ
    Circulation; 2006 Sep; 114(10):1063-9. PubMed ID: 16940194
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Copeptin, B-type natriuretic peptide and cystatin C are associated with incident symptomatic PAD.
    Fatemi S; Acosta S; Gottsäter A; Melander O; Engström G; Dakhel A; Zarrouk M
    Biomarkers; 2019 Sep; 24(6):615-621. PubMed ID: 31215249
    [No Abstract]   [Full Text] [Related]  

  • 39. N-terminal pro-brain natriuretic peptide in arterial hypertension: a valuable prognostic marker of cardiovascular events.
    Pedersen F; Raymond I; Kistorp C; Sandgaard N; Jacobsen P; Hildebrandt P
    J Card Fail; 2005 Jun; 11(5 Suppl):S70-5. PubMed ID: 15948105
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association between left atrial abnormality on ECG and vascular brain injury on MRI in the Cardiovascular Health Study.
    Kamel H; Bartz TM; Longstreth WT; Okin PM; Thacker EL; Patton KK; Stein PK; Gottesman RF; Heckbert SR; Kronmal RA; Elkind MS; Soliman EZ
    Stroke; 2015 Mar; 46(3):711-6. PubMed ID: 25677594
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.